Stephanie Enkel — ASN Events

Stephanie Enkel

The Kids Research Institute Australia, WA, Australia

  • This delegate is presenting an abstract at this event.
Dr. Stephanie Enkel is a public health researcher focused on reducing infectious-disease inequity through prevention-first, policy-informed, translational research. She has worked across research and policy to address the environmental and systems determinants of Streptococcus pyogenes and related infections, integrating field epidemiology, clinical trials, qualitative yarning, and economic evaluation. Dr. Enkel co-designs practical, scalable solutions with Aboriginal leaders and services to strengthen housing and hygiene infrastructure, improve vaccine acceptance and service delivery, and generate decision-grade evidence that shifts policy and practice under strong governance and Indigenous Data Sovereignty.
Presentations this author is a contributor to:

Household transmission of Streptococcus pyogenes (Strep A): a review to inform potential environmental health interventions for remote living Aboriginal communities at high risk of rheumatic fever (#274)

5:30 PM
Stephanie Enkel
Poster Session 2

School and clinical-based experimentation to ascertain Streptococcus pyogenes (Strep A)  transmission (#114)

5:30 PM
Stephanie Enkel
Poster Session 1

Population pharmacokinetics of penicillin G: insights into increased clearance at low concentrations to guide development of improved long-acting formulations for syphilis and prevention of rheumatic fever (#135)

5:30 PM
Laurens Manning
Poster Session 1

The experience of streptococcal pharyngitis human challenge trial participants (#284)

5:30 PM
Jane Oliver
Poster Session 2

The power of co-interpretation: reflections and learnings from an end-to-end partnership with remote Australian communities to tackle Strep A impetigo (118301)

2:39 PM
Hannah Thomas
Concurrent 1b - Control Begins in the Community

Development of a prototype for rapid point-of-care diagnosis of antibiotic-resistant Group A streptococcal and staphylococcal skin infections (#263)

5:30 PM
Kalindu Rodrigo
Poster Session 2

A randomised, double-blinded, placebo-controlled human challenge trial to establish the lowest penicillin concentration to prevent Streptococcus pyogenes pharyngitis (CHIPS). (118511)

9:39 AM
Laurens Manning
Plenary 5 - Interventions for Prevention

SToP (See, Treat, and Prevent) activities for skin disease control in remote Western Australia: a cluster randomised, stepped wedge Trial (117131)

9:51 AM
Stephanie Enkel
Plenary 5 - Interventions for Prevention